Coei Biotech Co.Ltd.H5.B55 The company was established in November 2020, focusing on the research and development ,production ,and sales of in vitro diagnostic reagent products. The company is equipped with a research and development center of 1100 square meters
and a production workshop of 1600 square meters,which not only supports molecular
diagnosis and immunochromatographic technology platforms,but also covers the development of new nano microspheres and other technologies in multiple fields,
fully meeting the needs of product trial production verification and providing comprehensive support for the smooth transformation of products.
Relying on mature technology platforms ,the company has deeply explored and developed more than ten products in the fields of molecular,pathological diagnosis
and immunochromatography,which have been successfully introduced to the market and widely used in various field. Nowadays,the company widely undertakes various
CDMO/OEM businesses.
Coei Biotech aims to create its own brand while providing services to other R&D enterprises,committed to providing one-stop solutions from product incubation to registration and listing.
